Joanna Crawford

Joanna Crawford

Auto-generated profile, based on publicly available information

Joanna Crawford

Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD, 4072, Australia

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2011 in Cell
Verified
Journal Article
Closed access
TMTim R. Mercer
Tim R. Mercer
SNShane Neph
Shane Neph
Marcel DingerMarcel Dinger
Marcel Dinger
JCJoanna Crawford
Joanna Crawford
MSMartin A. Smith
Martin A. Smith
JMJohn Mattick
John Mattick

13 November 2011 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
TMTim R Mercer
Tim R Mercer
DGDaniel J Gerhardt
Daniel J Gerhardt
Marcel DingerMarcel Dinger
Marcel Dinger
JCJoanna Crawford
Joanna Crawford
CTCole Trapnell
Cole Trapnell
JRJohn L Rinn
John L Rinn

31 May 2011 in Cancer Research
Verified
Journal Article
Closed access
PDF file
DKDivya Khaitan
Divya Khaitan
Marcel DingerMarcel Dinger
Marcel Dinger
JMJoseph Mazar
Joseph Mazar
JCJoanna Crawford
Joanna Crawford
MSMartin A. Smith
Martin A. Smith
RPRanjan J. Perera
Ranjan J. Perera
The identification of cancer-associated long noncoding RNAs (lncRNAs) and the investigation of their molecular and biological functions are important to understand the molecular biology of cancer and its progression. Although the functions of lncRNAs and the mechanisms regulating their expression are largely unknown, recent studies are beginning to unravel their importance in human health and disease. Here, we report that a number of lncRNAs are differentially expressed in melanoma cell lines in comparison to melanocytes and keratinocyte controls. One of these lncRNAs, SPRY4-IT1 (GenBank accession ID AK024556), is derived from an intron of the SPRY4 gene and is predicted to contain several long hairpins in its secondary structure. RNA-FISH analysis showed that SPRY4-IT1 is predominantly localized in the cytoplasm of melanoma cells, and SPRY4-IT1 RNAi knockdown results in defects in cell growth, differentiation, and higher rates of apoptosis in melanoma cell lines. Differential expression of both SPRY4 and SPRY4-IT1 was also detected in vivo, in 30 distinct patient samples, classified as primary in situ, regional metastatic, distant metastatic, and nodal metastatic melanoma. The elevated expression of SPRY4-IT1 in melanoma cells compared to melanocytes, its accumulation in cell cytoplasm, and effects on cell dynamics, including increased rate of wound closure on SPRY4-IT1 overexpression, suggest that the higher expression of SPRY4-IT1 may have an important role in the molecular etiology of human melanoma. Cancer Res; 71(11); 3852–62. ©2011 AACR.

1 April 2011 in RNA
Verified
Journal Article
Closed access
PDF file
MAMarjan Askarian-Amiri
Marjan Askarian-Amiri
JCJoanna Crawford
Joanna Crawford
JFJuliet D. French
Juliet D. French
CSChanel E. Smart
Chanel E. Smart
MSMartin A. Smith
Martin A. Smith
JMJohn Mattick
John Mattick
Long noncoding RNAs (lncRNAs) are increasingly recognized to play major regulatory roles in development and disease. To identify novel regulators in breast biology, we identified differentially regulated lncRNAs during mouse mammary development. Among the highest and most differentially expressed was a transcript (Zfas1) antisense to the 5′ end of the protein-coding gene Znfx1. In vivo, Zfas1 RNA is localized within the ducts and alveoli of the mammary gland. Zfas1 intronically hosts three previously undescribed C/D box snoRNAs (SNORDs): Snord12, Snord12b, and Snord12c. In contrast to the general assumption that noncoding SNORD-host transcripts function only as vehicles to generate snoRNAs, knockdown of Zfas1 in a mammary epithelial cell line resulted in increased cellular proliferation and differentiation, while not substantially altering the levels of the SNORDs. In support of an independent function, we also found that Zfas1 is extremely stable, with a half-life >16 h. Expression analysis of the SNORDs revealed these were expressed at different levels, likely a result of distinct structures conferring differential stability. While there is relatively low primary sequence conservation between Zfas1 and its syntenic human ortholog ZFAS1, their predicted secondary structures have similar features. Like Zfas1, ZFAS1 is highly expressed in the mammary gland and is down-regulated in breast tumors compared to normal tissue. We propose a functional role for Zfas1/ ZFAS1 in the regulation of alveolar development and epithelial cell differentiation in the mammary gland, which, together with its dysregulation in human breast cancer, suggests ZFAS1 as a putative tumor suppressor gene.

5 January 2015 in Genome Research
Verified
Journal Article
Open access
PDF file
TMTim R. Mercer
Tim R. Mercer
MCMichael B. Clark
Michael B. Clark
SAStacey B. Andersen
Stacey B. Andersen
MBMarion E. Brunck
Marion E. Brunck
WHWilfried Haerty
Wilfried Haerty
JMJohn Mattick
John Mattick
During the splicing reaction, the 5′ intron end is joined to the branchpoint nucleotide, selecting the next exon to incorporate into the mature RNA and forming an intron lariat, which is excised. Despite a critical role in gene splicing, the locations and features of human splicing branchpoints are largely unknown. We use exoribonuclease digestion and targeted RNA-sequencing to enrich for sequences that traverse the lariat junction and, by split and inverted alignment, reveal the branchpoint. We identify 59,359 high-confidence human branchpoints in >10,000 genes, providing a first map of splicing branchpoints in the human genome. Branchpoints are predominantly adenosine, highly conserved, and closely distributed to the 3′ splice site. Analysis of human branchpoints reveals numerous novel features, including distinct features of branchpoints for alternatively spliced exons and a family of conserved sequence motifs overlapping branchpoints we term B-boxes, which exhibit maximal nucleotide diversity while maintaining interactions with the keto-rich U2 snRNA. Different B-box motifs exhibit divergent usage in vertebrate lineages and associate with other splicing elements and distinct intron–exon architectures, suggesting integration within a broader regulatory splicing code. Lastly, although branchpoints are refractory to common mutational processes and genetic variation, mutations occurring at branchpoint nucleotides are enriched for disease associations.

1 November 1996 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
SASinoula Apostolou
Sinoula Apostolou
SWScott A. Whitmore
Scott A. Whitmore
JCJoanna Crawford
Joanna Crawford
GLGregory Lennon
Gregory Lennon
GSGrant R. Sutherland
Grant R. Sutherland
RMRobert K. Moyzis
Robert K. Moyzis